Hormones and health outcomes in aging men

Experimental Gerontology

Volumn 48, Issue 7, 2013, Pages 677-681

  Yeap, Bu B ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

Author keywords

Cardiovascular disease; Frailty; Male aging; Mortality; Sexual activity; Testosterone; Thyroxine

Indexed keywords

BIOLOGICAL MARKER; ESTRADIOL; GONADORELIN; HYDROCORTISONE; LIOTHYRONINE; LUTEINIZING HORMONE; PLACEBO; TESTOSTERONE; THYROTROPIN; THYROXINE;

AGING; ARTICLE; BONE DENSITY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; FRAIL ELDERLY; FREE THYROXINE INDEX; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HORMONE ACTION; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; ISCHEMIC HEART DISEASE; MENOPAUSE; MUSCLE MASS; MUSCLE STRENGTH; OBSERVATIONAL STUDY; OSTEOLYSIS; PENIS ERECTION; PHYSICAL ACTIVITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SEXUAL BEHAVIOR; TESTOSTERONE BLOOD LEVEL; THYROID DISEASE; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; AGING; GONADS; HEALTH STATUS; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; PITUITARY GLAND; SEX FACTORS; TESTOSTERONE; THYROID GLAND; THYROXINE;

EID: 84879012016     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2012.07.012     Document Type: Article

References (61)

1. Abbott R.D., Launer L.J., Rodriguez B.L., Ross G.W., Wilson P.W.F., Masaki K.H., Strozyk D., Curb J.D., Yano K., Popper J.S., Petrovitch H. Serum estradiol and risk of stroke in elderly men. Neurology 2007, 68:563-568.
2. Ahmed N., Mandel R., Fain M.J. Frailty: an emerging geriatric syndrome. Am. J. Med. 2007, 120:748-753.
3. Allan C.A., Forbes E.A., Strauss B.J.G., McLachlan R.I. Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency. Int. J. Impot. Res. 2008, 20:396-401.
4. Araujo A.B., Dixon J.M., Suarez E.A., Murad M.H., Guey L.T., Wittert G.A. Endogenous testosterone and mortality in men: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2011, 96:3007-3019.
5. Arnlov J., Pencina M.J., Amin S., Nam B.-H., Benjamin E.J., Murabito J.M., Wang T.J., Knapp P.E., D'Agostino R.B., Bhasin S., Vasan R.S. Endogenous sex hormones and cardiovascular disease incidence in men. Ann. Intern. Med. 2006, 145:176-184.
6. Basaria S., Coviello A.D., Travison T.G., Storer T.W., Farwell W.R., Jette A.M., Eder R., Tennstedt S., Ulloor J., Zhang A., Choong K., Lakshman K.M., Mazer N.A., Miciek R., Krasnoff J., Elmi A., Knapp P.E., Brooks B., Appleman E., Aggarwal S., Bhasin G., Hede-Brierley L., Bhatia A., Collins L., LeBrasseur N., Fiore L.D., Bhasin S. Adverse events associated with testosterone administration. N. Engl. J. Med. 2010, 363:109-122.
7. Berry J.D., Dyer A., Cai X., Garside D.B., Ning H., Thomas A., Greenland P., Van Horn L., Tracy R.P., Lloyd-Jones D. Lifetime risks of cardiovascular disease. N. Eng. J. Med. 2012, 366:321-329.
8. Bhasin, S., 2008. Testicular disorders, In: Kronenberg, H.M., Melmed, S., Polonsky, K.S., Larsen, P.R. (Eds.), Williams Textbook of Endocrinology, 11th Edition. Saunders Elsevier, Philadelphia, pp. 645-699
9. Bhasin S., Woodhouse L., Casaburi R., Singh A.B., Mac R.P., Lee M., Yarasheski K.E., Sinha-Hikim I., Dzekov C., Dzekov J., Magliano L., Storer T.W. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J. Clin. Endocrinol. Metab. 2005, 90:678-688.
10. Bhasin S., Cunningham G.R., Hayes F.J., Matsumoto A.M., Snyder P.J., Swerdloff R.S., Montori V.M. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2010, 95:2536-2559.
11. Bremner A.P., Feddema P., Leedman P.J., Brown S.J., Beilby J.P., Lim E.M., Wilson S.G., O'Leary P.C., Walsh J.P. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J. Clin. Endocrinol. Metab. 2012, 97:1554-1562.
12. Collet T.-H., Gussekloo J., Bauer D.C., den Elzen W.P.J., Cappola A.R., Balmer P., Iervasi G., Asvold B.O., Sgarbi J.A., Volzke H., Gencer B., Maciel R.M.B., Molinaro S., Bremner A., Luben R.N., Maisonneuve P., Cornuz J., Newman A.B., Khaw K.-T., Westendorp R.G.J., Franklyn J.A., Vittinghoff E., Walsh J.P., Rodondi N. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch. Intern. Med. 2012, 10.1001/archinternmed.2012.402.
13. Cooper D.S., Biondi B. Subclinical thyroid disease. Lancet 2012, 379:1142-1154.
14. Cooper C., Dere W., Evans W., Kanis J.A., Rizzoli R., Sayer A.A., Sieber C.C., Kaufman J.-M., Van Kan G.A., Boonen S., Adachi J., Mitlak B., Tsouderos Y., Rolland Y., Reginster J.-Y.L. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos. Int. 2012, 10.1007/s00198-012-1913-1.
15. Corona G., Rastrelli G., Monami M., Guay A., Buvat J., Sforza A., Forti G., Mannucci E., Maggi M. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur. J. Endocrinol. 2011, 165:687-701.
16. Cunningham G.R., Toma S.M. Why is androgen replacement in males controversial?. J. Clin. Endocrinol. Metab. 2011, 96:38-52.
17. Feldman H.A., Longcope C., Derby C.A., Johannes C.B., Araujo A.B., Coviello A.D., Bremner W.J., McKinlay J.B. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab. 2002, 87:589-598.
18. Fernandez-Balsells M.M., Murad M.H., Lane M., Lampropulos J.F., Albuquerque F., Mullan R.J., Agrwal N., Elamin M.B., Gallegos-Orozco J.F., Wang A.T., Erwin P.J., Bhasin S., Montori V.M. Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2010, 95:2560-2575.
19. Ford E.S., Capewell S. Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care. Annu. Rev. Public Health 2011, 32:5-22.
20. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., Seeman T., Tracy R., Kop W.J., Burke G., McBurnie M.A. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 2001, 56:M146-M156.
21. Gammage M.D., Parle J.V., Holder R.L., Roberts L.M., Hobbs F.D.R., Wilson S., Sheppard M.C., Franklyn J.A. Association between serum free thyroxine concentration and atrial fibrillation. Arch. Intern. Med. 2007, 167:928-934.
22. Gennari L., Nuti R., Bilezikian J.P. Aromatase activity and bone homeostasis in men. J. Clin. Endocrinol. Metab. 2004, 89:5898-5907.
23. Haddad R.M., Kennedy C.C., Caples S.M., Tracz M.J., Bolona E.R., Sideras K., Uraga M.V., Erwin P.J., Montori V.M. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin. Proc. 2007, 82:29-39.
24. Harman S.M., Metter E.J., Tobin J.D., Pearson J., Blackman M.R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J. Clin. Endocrinol. Metab. 2001, 86:724-731.
25. Hyde Z., Flicker L., Almeida O.P., Hankey G.J., McCaul K.A., Chubb S.A.P., Yeap B.B. Low free testosterone predicts frailty in older men. The Health in Men Study. J. Clin. Endocrinol. Metab. 2010, 95:3165-3172.
26. Hyde Z., Flicker L., Hankey G.J., Almeida O.P., McCaul K.A., Chubb S.A.P., Yeap B.B. Prevalence of sexual activity and associated factors in men aged 75-95 years: a cohort study. Ann. Intern. Med. 2010, 153:693-702.
27. Hyde Z., Norman P.E., Flicker L., Hankey G.J., McCaul K.A., Almeida O.P., Chubb S.A.P., Yeap B.B. Elevated luteinizing hormone predicts ischaemic heart disease events in older men. The Health In Men Study. Eur. J. Endocrinol. 2011, 164:569-577.
28. Hyde Z., Norman P.E., Flicker L., Hankey G.J., Almeida O.P., McCaul K.A., Chubb S.A.P., Yeap B.B. Low free testosterone predicts mortality from cardiovascular disease but not other causes: the Health In Men Study. J. Clin. Endocrinol. Metab. 2012, 97:179-189.
29. Isidori A.M., Giannetta E., Greco E.A., Gianfrilli D., Bonifacio V., Isidori A., Lenzi A., Fabbri A. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin. Endocrinol. 2005, 63:280-293.
30. Isidori A.M., Giannetta E., Gianfrilli D., Greco E.A., Bonifacio V., Aversa A., Isidori A., Fabbri A., Lenzi A. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin. Endocrinol. 2005, 63:381-394.
31. Kaufman J.M., Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev. 2005, 26:833-876.
32. Kelleher S., Conway A.J., Handelsman D.J. Blood testosterone threshold for androgen deficiency symptoms. J. Clin. Endocrinol. Metab. 2004, 89:3813-3817.
33. Khosla S., Melton L.J., Riggs B.L. Estrogen and the male skeleton. J. Clin. Endocrinol. Metab. 2002, 87:1443-1450.
34. Krasnoff J.B., Basaria S., Pencina M.J., Jasuja G.K., Vasan R.S., Ulloor J., Zhang A., Coviello A., Kelly-Hayes M., D'Agostino R.B., Wolf P.A., Bhasin S., Murabito J.M. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling older men: the Framingham Offspring Study. J. Clin. Endocrinol. Metab. 2010, 95:2790-2799.
35. Larsen P.R., Davies T.F., Schlumberger M.-J., Hay I.D. Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. Williams Textbook of Endocrinology 2008, 299-332. Saunders Elsevier, Philadelphia. 11th Edition. H.M. Kronenberg, S. Melmed, K.S. Polonsky, P.R. Larsen (Eds.).
36. LeBlanc E.S., Wang P.Y., Lee C.G., Barrett-Connor E., Cauley J.A., Hoffman A.R., Laughlin G.A., Marshall L.M., Orwoll E.S. Higher testosterone levels are associated with less loss of lean body mass in older men. J. Clin. Endocrinol. Metab. 2011, 96:3855-3863.
37. Liu P.Y., Beilin J., Meier C., Nguyen T.V., Center J.R., Leedman P.J., Seibel M.J., Eisman J.A., Handelsman D.J. Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate cohorts. J. Clin. Endocrinol. Metab. 2007, 92:3599-3603.
38. Murphy E., Gluer C.C., Reid D.M., Felsenberg D., Roux C., Eastell R., Williams G.R. Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of non-vertebral fractures in healthy euthyroid postmenopausal women. J. Clin. Endocrinol. Metab. 2010, 95:3173-3181.
39. O'Connell M.D.L., Roberts S.A., Srinavas-Shankar U., Tajar A., Connolly M.J., Adams J.E., Oldham J.A., Wu F.C.W. Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men?. J. Clin. Endocrinol. Metab. 2011, 96:454-458.
40. O'Donnell A.B., Travison T.G., Harris S.S., Tenover J.L., McKinlay J.B. Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab. 2006, 91:425-431.
41. Ochs N., Auer R., Bauer D.C., Nanchen D., Gussekloo J., Cornuz J., Rodondi N. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann. Intern. Med. 2008, 148:832-845.
42. Ohlsson C., Barrett-Connor E., Bhasin S., Orwoll E., Labrie F., Karlsson M.K., Ljundggren O., Vandenput L., Mellstrom D., Tivesten A. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. J. Am. Coll. Cardiol. 2011, 58:1674-1681.
43. Page S.T., Amory J.K., Bowman D., Anawalt B.D., Matsumoto A.M., Bremner W.J., Tenover J.L. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J. Clin. Endocrinol. Metab. 2005, 90:1502-1510.
44. Rodondi N., den Elzen W.P., Bauer D.C., Cappola A.R., Razvi S., Walsh J.P., Asvold B.O., Iervasi G., Imaizumi M., Collet T.H., Bremner A., Maisonneuve P., Sgarbi J.A., Khaw K.T., Vanderpump M.P., Newman A.B., Cornuz J., Franklyn J.A., Westendorp R.G., Vittinghoff E., Gussekloo J. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010, 304:1365-1374.
45. Rodriguez-Manas L., Feart C., Mann G., Vina J., Chatterji S., Chodzko-Zajko W., Harmand M.G.-C., Bergman H., Carcaillon L., Nicholson C., Scuteri A., Sinclair A., Pelaez M., Van der Cammen T., Beland F., Bickenbach J., Delamarche P., Ferrucci L., Fried L.P., Gutierrez-Robledo L.M., Rockwood K., Artajelo F.R., Serviddio G., Vega E. Searching for an operational definition of frailty: the Frailty Operative Definition-Consensus Conference Project. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 10.1093/Gerona/gls119.
46. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., Carnethon M.R., Dai S., de Simone G., Ford E.S., Fox C.S., Fullerton H.J., Gillespie C., Greenlund K.J., Hailpern S.M., Heit J.A., Ho P.M., Howard V.J., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Makuc D.M., Marcus G.M., Marelli A., Matchar D.B., McDermott M.M., Meigs J.B., Moy C.S., Mozaffarian D., Mussolino M.E., Nichol G., Paynter N.P., Rosamond W.D., Sorlie P.D., Stafford R.S., Turan T.N., Turner M.B., Wong N.D., Wylie-Rosett J. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
47. Roos A., Bakker S.J.L., Links T.P., Gans R.O.B., Wolffenbuttel B.H.R. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J. Clin. Endocrinol. Metab. 2007, 92:491-496.
48. Smith G.D., Ben-Shlomo Y., Beswick A., Yarnell J., Lightman S., Elwood P. Cortisol, testosterone, and coronary heart disease. Prospective evidence from the Caerphilly Study. Circulation 2005, 112:332-340.
49. Somwaru L.L., Rariy C.M., Arnold A.M., Cappola A.R. The natural history of subclinical hypothyroidism in the elderly: the Cardiovascular Health Study. J. Clin. Endocrinol. Metab. 2012, 10.1210/jc.2011-3047.
50. Srinavas-Shankar U., Roberts S.A., Connolly M.J., O'Connell M.D.L., Adams J.E., Oldham J.A., Wu F.C.W. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 2010, 95:639-650.
51. Surks M.I., Boucai L. Age- and race-based serum thyrotrophin reference limits. J. Clin. Endocrinol. Metab. 2010, 95:496-502.
52. Travison T.G., Nguyen A.-H., Naganathan V., Stanaway F.F., Blyth F.M., Cumming R.G., Le Couteur D.G., Sambrook P.N., Handelsman D.J. Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the Concord Health and Ageing in Men Project. J. Clin. Endocrinol. Metab. 2011, 96:2464-2474.
53. United Nations, Department of Economic and Social Affairs, Population Division World Population Ageing: 1950-2050 2001, United Nations, New York.
54. Van Kan G.A., Rolland Y., Bergman H., Morley J.E., Kritchevsky S.B., Vellas B. The I.A.N.A. task force on frailty assessment of older people in clinical practice. J. Nutr. Health Aging 2008, 12:29-37.
55. Vikan T., Schirmer H., Njolstad I., Svartberg J. Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromso Study. Eur. J. Endocrinol. 2009, 161:435-442.
56. Wu F.C.W., Tajar A., Beynon J.M., Pye S.R., Silman A.J., Finn J.D., O'Neill T.W., Bartfai G., Casanueva F.F., Forti G., Giwercman A., Han T.S., Kula K., Lean M.E.J., Pendleton N., Punab M., Boonen S., Vanderschueren D., Labrie F., Huhtaniemi I.T. Identification of late-onset hypogonadism in middle-aged and elderly men. N. Engl. J. Med. 2010, 363:123-135.
57. Yeap B.B. Testosterone and ill-health in aging men. Nat. Clin. Pract. Endocrinol. Metab. 2009, 5:113-121.
58. Yeap B.B. Androgens and cardiovascular disease. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17:269-276.
59. Yeap B.B. Testosterone and sex in older men. Med. J. Aust. 2011, 195:61-62.
60. Yeap B.B., Hyde Z., Almeida O.P., Norman P.E., Chubb S.A.P., Jamrozik K., Flicker L., Hankey G.J. Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J. Clin. Endocrinol. Metab. 2009, 94:2353-2359.
61. Yeap B.B., Alfonso H., Chubb S.A.P., Walsh J.P., Hankey G.J., Almeida O.P., Flicker L. Higher free thyroxine levels are associated with frailty in older men. The Health In Men Study. Clin. Endocrinol. 2012, 76:741-748.